Pancreatic Acinar Cell Carcinoma Active Not Recruiting Phase 1 Trials for Sargramostim (DB00020)

IndicationStatusPhase
DBCOND0040329 (Pancreatic Acinar Cell Carcinoma)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00669734Vaccine Therapy and Sargramostim in Treating Patients With Pancreas Cancer That Cannot Be Removed By SurgeryTreatment